Mercury bioconversion module-based biosensor with variable detection range and application thereof in biological sample detection
By constructing recombinant bacteria A and B, using mercury sensing module and reporting module, the problem of the impact of the detection accuracy of high-concentration mercury in the existing technology is solved, and effective detection of high-concentration inorganic divalent mercury and organic mercury is achieved, which improves the Sensor tolerance and detection accuracy.
Patent Information
- Application Number
- CN202411049273.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-01
- Publication Date
- 2024-12-03
AI Technical Summary
In the prior art, when detecting high concentrations of mercury, the bacterial activity of the biosensor decreases, resulting in the impact of the accuracy of the detection results, and the tolerance to divalent mercury and organic mercury is insufficient, making it difficult to achieve accurate monitoring of high concentration samples.
Recombinant bacteria A and Recombinant bacteria B are constructed, which are used to detect inorganic divalent mercury and organic mercury respectively. By introducing specific DNA fragments and gene clusters, a mercury sensing module and a reporting module are constructed to improve the tolerance and detection of high concentrations of mercury. scope.
It realizes effective detection of high concentrations of inorganic divalent mercury and organic mercury, improves the tolerance and detection accuracy of the sensor, is suitable for monitoring of urine mercury and blood mercury, and overcomes the existing sensors' high concentration of mercury detection. Decreased activity problem.
Smart Images

Figure BDA0004974426990000071 
Figure BDA0004974426990000081 
Figure BDA0004974426990000082
Abstract
Description
Technical Field
[0001] The invention relates to the field of biotechnology, and in particular to a biosensor with a variable detection range based on a mercury bioconversion module and its application in biological sample detection. Background Art
[0002] Mercury is a highly toxic metal and is listed as one of the top ten harmful elements in the world due to its persistence, bioaccumulation and toxicity in the environment. The main target organ of inorganic mercury is the kidney. In the short term, during acute mercury exposure, the main symptoms are skin problems, causing dermatitis, nail discoloration, mucosal corrosion and corrosive burns, while long-term exposure to mercury pollution can cause anorexia, fatigue, irritability, apathy, photophobia and other hypersensitivity-related reactions. Among all forms of mercury, methylated mercury (MeHg) is the most toxic form to organisms because it can cross the blood-brain and placental barriers and cause serious neurological damage. Methylmercury accounts for only 2% of the total mercury in the soil, but this form plays an important role in the biomagnification process, that is, the concentration of harmful substances in each level of the food chain increases step by step.
[0003] At present, commonly used laboratory mercury detection methods include atomic absorption spectrometry (AAS), atomic emission spectrometry (AES), atomic fluorescence spectrometry (AFS), inductively coupled plasma mass spectrometry (ICP-MS), etc. These methods often require complex and time-consuming pre-treatment methods for the detection of mercury in water, soil or biological samples, and have restrictions on detection personnel and locations. For example, the most commonly used methods for determining mercury in urine and blood are cold vapor atomic fluorescence spectrometry (CVAFS) and atomic absorption spectrometry. (CVAAS) obtains the total mercury content. To further determine the form of mercury, it is necessary to connect to chromatography or mass spectrometry for resolution. Therefore, it is particularly important to develop more economical, convenient and rapid methods as a supplement to traditional detection methods.
[0004] In anoxic or partially anoxic aquatic environments, mercury (II) can be methylated to methylmercury, which is neurotoxic and cardiotoxic, and can further bioaccumulate and biomagnify in aquatic food chains, thereby endangering human health. However, synthetic methylmercury can be degraded to mercury (II) in surface waters and sediments, and / or further reduced to Hg(0), increasing mercury flux to the atmosphere. Microorganisms play a vital role in these transformation processes of mercury. Whole-cell sensors contain one or more microorganisms that can recognize the analyte and generate a measurable output signal, thereby qualitatively or quantitatively determining the concentration of the analyte and achieving highly selective identification of the target metal. This has positive significance for the detection of urinary mercury and blood mercury, and is expected to become a powerful supplement to mainstream instrument detection methods. Summary of the invention
[0005] The object of the present invention is to provide a biosensor with a variable detection range based on a mercury bioconversion module and its application in biological sample detection.
[0006] In a first aspect, the present invention claims protection for a recombinant bacterium.
[0007] The recombinant bacteria claimed in the present invention are recombinant bacteria A or recombinant bacteria B;
[0008] The recombinant bacteria A is obtained by introducing a recombinant vector A into a recipient bacterium; the recombinant vector A contains a DNA fragment A; the DNA fragment A contains a mercury sensing element, a vioABCE gene cluster and a divalent mercury reductase element;
[0009] The recombinant bacteria B is obtained by introducing a recombinant vector B into a recipient bacterium; the recombinant vector B contains a DNA fragment B; the DNA fragment B contains the mercury sensing element, the vioABCE gene cluster, the organic mercury lyase element and the divalent mercury reductase element;
[0010] The mercury sensing element includes merR gene and Pmer;
[0011] The divalent mercury reductase element includes a constitutively expressed merA gene;
[0012] The organomercury lyase element includes a constitutively expressed merB gene;
[0013] The merR gene encodes a mercury ion-responsive transcriptional regulator, namely, the merR protein;
[0014] The merA gene encodes divalent mercury reductase, i.e., merA protein;
[0015] The merB gene encodes an organic mercury lyase, i.e., the merB protein;
[0016] The Pmer is a bidirectional promoter, which activates the expression of the merR gene in one direction and the expression of the vioABCE gene cluster in the other direction; the promoter activity of the Pmer for the merR gene is a constitutive promoter activity; the mercury ion responsive transcriptional regulator binds to the Pmer and inhibits the promoter activity of the Pmer for the vioABCE gene cluster.
[0017] The vioABCE gene cluster encodes vioA protein, vioB protein, vioC protein and vioE protein.
[0018] Furthermore, the nucleotide sequence of the Pmer may be positions 442-512 of SEQ ID No.1.
[0019] Furthermore, the amino acid sequence of the MerR protein may be as shown in SEQ ID No.2.
[0020] Furthermore, the amino acid sequence of the VioA protein may be as shown in SEQ ID No.3.
[0021] Furthermore, the amino acid sequence of the VioB protein may be as shown in SEQ ID No.4.
[0022] Furthermore, the amino acid sequence of the VioC protein may be as shown in SEQ ID No.5.
[0023] Furthermore, the amino acid sequence of the VioE protein may be as shown in SEQ ID No.6.
[0024] Furthermore, the amino acid sequence of the MerA protein may be as shown in SEQ ID No.7.
[0025] Furthermore, the amino acid sequence of the MerB protein may be as shown in SEQ ID No.8.
[0026] Furthermore, the nucleotide sequence of the MerR gene is the reverse complementary sequence of positions 7-441 of SEQ ID No.1.
[0027] Furthermore, the nucleotide sequence of the gene encoding the VioA protein is positions 555-1811 of SEQ ID No.1.
[0028] Furthermore, the nucleotide sequence of the gene encoding the VioB protein is positions 1829-4825 of SEQ ID No.1.
[0029] Furthermore, the nucleotide sequence of the gene encoding the VioC protein is positions 4843-6165 of SEQ ID No.1.
[0030] Furthermore, the nucleotide sequence of the gene encoding the VioE protein is positions 6183-6758 of SEQ ID No.1.
[0031] Furthermore, the nucleotide sequence of the vioABCE gene is positions 555-6758 of SEQ ID No.1.
[0032] Furthermore, the nucleotide sequence of MerA is positions 6868-8562 of SEQ ID No.1.
[0033] Furthermore, the nucleotide sequence of MerB is positions 8672-9310 of SEQ ID No.1.
[0034] In one embodiment of the present invention, the nucleotide sequence of the DNA fragment A is positions 1-8568 of SEQ ID No.1.
[0035] In one embodiment of the present invention, the nucleotide sequence of the DNA fragment B is SEQ ID No.1.
[0036] In one embodiment of the present invention, the recombinant vector A is obtained by replacing the small fragment between the restriction sites BglII and HindIII of the pET-21a(+) plasmid with the DNA fragment A (positions 1-8568 of SEQ ID No. 1).
[0037] In one embodiment of the present invention, the recombinant vector B is obtained by replacing the small fragment between the restriction sites BglII and XhoI of the pET-21a(+) plasmid with the DNA fragment B (SEQ ID No. 1).
[0038] Wherein, the recipient bacteria may be Escherichia coli.
[0039] In one embodiment of the present invention, the Escherichia coli is Escherichia coli TOP10.
[0040] In a second aspect, the present invention claims protection for any of the following applications:
[0041] (A1) Use of the recombinant bacterium A described in the first aspect as or in the preparation of a whole-cell biosensor for detecting inorganic divalent mercury;
[0042] (A2) Use of the recombinant bacterium B described in the first aspect as or in the preparation of a whole-cell biosensor for detecting organic mercury.
[0043] In (A1), the detection of inorganic divalent mercury is the detection of high-concentration inorganic divalent mercury; the high-concentration inorganic divalent mercury means that the content of inorganic divalent mercury in the test sample is in the range of 0.9766-15.625 μM.
[0044] In (A2), the detection of organic mercury is the detection of high-concentration organic mercury; the high-concentration organic mercury means that the content of organic mercury in the test sample is in the range of 0.125-1 μM.
[0045] In a third aspect, the present invention claims protection for any of the following products or applications:
[0046] P1, the recombinant vector A described in the first aspect above;
[0047] P2, the recombinant vector B described in the first aspect above;
[0048] P3, the DNA fragment A described in the first aspect above;
[0049] P4, the DNA fragment B described in the first aspect above;
[0050] Use of the recombinant vector A in P5 and P1 or the DNA fragment A in P3 in preparing the recombinant bacteria A in the first aspect above;
[0051] Use of the recombinant vector B in P6 and P2 or the DNA fragment B in P4 in preparing the recombinant bacteria B described in the first aspect above;
[0052] Use of the recombinant vector A described in P7 and P1, or the DNA fragment A described in P3, or the recombinant bacteria A described in the first aspect above in the preparation of a kit for detecting inorganic divalent mercury;
[0053] Use of the recombinant vector B described in P8 and P2 or the DNA fragment B described in P4 or the recombinant bacteria B described in the first aspect above in the preparation of a kit for detecting organic mercury;
[0054] P9. A kit for detecting inorganic divalent mercury, any one of the following (a1) to (a3):
[0055] (a1) containing the recombinant bacteria A described in the first aspect above;
[0056] (a2) containing the recombinant vector A and the recipient bacteria described in P1;
[0057] (a3) containing the DNA fragment A, expression vector and recipient bacteria described in P3;
[0058] P10. A kit for detecting organic mercury, any one of the following (b1) to (b3):
[0059] (b1) containing the recombinant bacteria B described in the first aspect above;
[0060] (b2) containing the recombinant vector B and the recipient bacteria described in P2;
[0061] (b3) containing the DNA fragment B described in P4, an expression vector and a recipient bacterium;
[0062] Further, in P9 and P10, the recipient bacteria may be Escherichia coli;
[0063] In one embodiment of the present invention, the Escherichia coli is Escherichia coli TOP10.
[0064] Application of the kit described in P11 and P9 in detecting inorganic divalent mercury;
[0065] Application of the kit described in P12 and P10 in the detection of organic mercury.
[0066] In P7 and P9, the detection of inorganic divalent mercury is the detection of high-concentration inorganic divalent mercury; the high-concentration inorganic divalent mercury means that the content of inorganic divalent mercury in the test sample is in the range of 0.9766-15.625 μM.
[0067] In P8 and P10, the detection of organic mercury is the detection of high-concentration organic mercury; the high-concentration organic mercury means that the content of organic mercury in the test sample is in the range of 0.125-1 μM.
[0068] In a fourth aspect, the present invention claims protection for any of the following methods:
[0069] Method I: A method for detecting inorganic divalent mercury, comprising the following steps: co-incubating the recombinant bacteria A described in the first aspect above with a test sample;
[0070] Method II: A method for detecting organic mercury, comprising the following steps: the recombinant bacteria B described in the first aspect above is co-incubated with a test sample.
[0071] Furthermore, in the method I, the content of inorganic divalent mercury in the test sample is 0.9766-15.625 μM.
[0072] Furthermore, in the method II, the content of organic mercury in the test sample is 0.125-1 μM.
[0073] Further, in the method, the co-incubation is carried out in a liquid phase system. In the implementation case of the present invention, the liquid phase system is LB liquid culture medium or artificial urine sample or blood sample. That is, the test sample is LB liquid culture medium or artificial urine sample or blood sample containing inorganic divalent mercury and / or organic mercury.
[0074] Furthermore, in the method, the co-incubation conditions may be: 37° C., 250 rpm shaking culture.
[0075] Furthermore, in the method I, the co-incubation time may be 1-7 hours, such as 4 hours.
[0076] Furthermore, in the method II, the co-incubation time may be 1-9 hours, such as 5 hours.
[0077] Furthermore, in the method, after the co-incubation is completed, it can be determined whether the test sample contains inorganic divalent mercury and / or organic mercury based on the color of the system.
[0078] Furthermore, the method may also include the following steps: after the co-incubation is completed, sampling is performed, and then extraction is performed with n-butanol and the organic phase is collected, and the OD570 value of the organic phase is detected.
[0079] For the above-mentioned related aspects, the detection of inorganic divalent mercury and the detection of organic mercury can be either qualitative detection or quantitative detection.
[0080] For the above-mentioned related aspects, the organic mercury is methylmercury. The organic mercury can be in the form of the following compounds: methylmercury chloride, phenylmercury acetate, diphenylmercury or 4-chloromercury benzoate, etc. The inorganic divalent mercury can be mercury chloride, etc.
[0081] The present invention uses MerR, MerA and MerR, MerA, MerB as sensing modules and the synthetic gene of violacein and its intermediates as reporting modules to construct a sensor for monitoring divalent mercury and organic mercury (mainly methylmercury), and explores the feasibility of its application in monitoring urine mercury and blood mercury in occupational groups.
[0082] Compared with the existing sensors (such as CN 117737105A), the sensor (recombinant bacteria) constructed by the present invention has a higher tolerance to divalent mercury and organic mercury (mainly methyl mercury), and effectively solves the problem that when the existing sensors are used for high-concentration mercury detection, the toxicity of mercury causes the activity of bacteria to decrease or even die, thereby affecting the accuracy of the detection result (the detection result is low). Compared with the existing biosensors, the linear range of the biosensor of the present invention moves to the right, and is suitable for monitoring high-concentration samples of divalent mercury and organic mercury (such as urine mercury or blood mercury). BRIEF DESCRIPTION OF THE DRAWINGS
[0083] Figure 1 Schematic diagram of the working principle of detecting inorganic divalent mercury using the recombinant bacteria TOP10 / pHg-DV-A.
[0084] Figure 2 Schematic diagram of the working principle of detecting organic mercury using the recombinant bacteria TOP10 / pHg-DV-AB.
[0085] Figure 3 It is the mercury residue in the bacterial solution detected directly by a mercury meter after adding a certain amount of inorganic mercury into the bacterial solution during the logarithmic phase.
[0086] Figure 4 The time-dose curves and dose-effect curves of the delayed-phase recombinant bacteria TOP10 / pHg-DV and TOP10 / pHg-DV-A in response to different concentrations of divalent mercuric ions. A is the time-pigment accumulation curve of the recombinant bacteria in different concentrations of divalent mercuric ions and the representative photos of the time-dose of the recombinant bacteria extract; B is the dose-response curve of the recombinant bacteria in different divalent mercuric ion concentrations and the representative photos of the dose effect of the recombinant bacteria extract.
[0087] Figure 5The time-dose curves and dose-effect curves of the response of the recombinant bacteria TOP10 / pHg-DV and TOP10 / pHg-DV-A to different concentrations of divalent mercuric ions in the logarithmic phase. A is the time-pigment accumulation curve of the recombinant bacteria in different concentrations of divalent mercuric ions and the representative photos of the time-dose of the recombinant bacteria extract; B is the dose-response curve of the recombinant bacteria in different concentrations of divalent mercuric ions and the representative photos of the dose effect of the recombinant bacteria extract.
[0088] Figure 6 A is the result graph of TOP10 / pHg-DV-A's response to different metals and a representative photo of the recombinant bacterial extract; A is the response graph of TOP10 / pHg-DV-A to mercury under different single metal interference conditions and a representative photo of the recombinant bacterial extract. B is the response graph of TOP10 / pHg-DV-A to mercury under different mixed metal interference conditions and a representative photo of the recombinant bacterial extract.
[0089] Figure 7 It is the mercury residue in the bacterial solution detected directly by a mercury meter after adding quantitative organic mercury into the bacterial solution during the logarithmic phase.
[0090] Figure 8 The time-dose curves and dose-effect curves of the delayed-phase recombinant bacteria TOP10 / pHg-DV-B and TOP10 / pHg-DV-AB in response to different concentrations of organic mercury ions. A is the time-pigment accumulation curve of the recombinant bacteria in different concentrations of organic mercury and the representative photo of the time-dose of the recombinant bacteria extract; B is the dose-response curve of the recombinant bacteria in different concentrations of organic mercury and the representative photo of the dose effect of the recombinant bacteria extract.
[0091] Fig. 9 The time-dose curves and dose-effect curves of the response of the recombinant bacteria TOP10 / pHg-DV-B and TOP10 / pHg-DV-AB to different concentrations of organic mercury in the logarithmic phase. A is the time-pigment accumulation curve of the recombinant bacteria in different concentrations of organic mercury and the representative photos of the time-dose of the recombinant bacteria extract; B is the dose-response curve of the recombinant bacteria in different concentrations of organic mercury and the representative photos of the dose effect of the recombinant bacteria extract.
[0092] Fig.10 The graph shows the dose-effect relationship of the recombinant bacteria TOP10 / pHg-DV-AB in response to various organic mercury species and a representative photograph of the dose-effect of the recombinant bacteria extract.
[0093] Fig.11The following are histograms of bacterial concentration and pigment of recombinant bacteria TOP10 / pHg-DV-A and TOP10 / pHg-DV-AB during the passage process. A is a histogram of bacterial concentration during the passage process of TOP10 / pHg-DV-A (the legend is the mercury concentration, in μM); B is a histogram of pigment during the passage process of TOP10 / pHg-DV-A (the legend is the mercury concentration); C is a histogram of bacterial concentration during the passage process of TOP10 / pHg-DV-AB (the legend is the mercury concentration, in μM); D is a histogram of pigment during the passage process of TOP10 / pHg-DV-AB (the legend is the mercury concentration, in μM).
[0094] Fig.12 The application of recombinant bacteria TOP10 / pHg-DV and TOP10 / pHg-DV-A in the detection of inorganic mercury in artificial urine. A is the dose-pigment accumulation relationship of recombinant bacteria on urinary mercury and representative photos of recombinant bacteria extracts and biological exposure limits and normal reference values (estimated according to the creatinine concentration level of normal human urine), as indicated by red arrows; B is the regression analysis of the relationship between TOP10 / pHg-DV pigment signal and urinary mercury dose; C is the regression analysis of the relationship between TOP10 / pHg-DV-A pigment signal and urinary mercury dose, x-axis: Hg(II) concentration is displayed in log2 scale.
[0095] Fig.13 The application of recombinant bacteria TOP10 / pHg-DV-B and TOP10 / pHg-DV-AB in the detection of organic mercury in blood. A is the dose-pigment accumulation relationship of recombinant bacteria on blood mercury and representative photos and biological exposure limits of recombinant bacteria extracts, as indicated by red arrows; B is the regression analysis of the relationship between TOP10 / pHg-DV-B pigment signal and blood mercury dose; C is the regression analysis of the relationship between TOP10 / pHg-DV-AB pigment signal and blood mercury dose. DETAILED DESCRIPTION
[0096] The present invention is further described in detail below in conjunction with specific embodiments, and the examples provided are only for illustrating the present invention, rather than for limiting the scope of the present invention. The examples provided below can be used as a guide for further improvements by those of ordinary skill in the art, and do not constitute a limitation of the present invention in any way.
[0097] The experimental methods in the following examples, unless otherwise specified, are all conventional methods, and are performed according to the techniques or conditions described in the literature in the field or according to the product instructions. The materials, reagents, etc. used in the following examples, unless otherwise specified, can all be obtained from commercial channels.
[0098] The quantitative data in the following examples are all average values of three replicates.
[0099] Example 1. Construction of whole-cell biosensor
[0100] 1. Construction of recombinant plasmids pHg-DV-A and pHg-DV-AB
[0101] DNA molecule A is used to replace the small segment between the NdeI restriction enzyme recognition sequence and the SacI restriction enzyme recognition sequence in the pET-21a(+) plasmid (the replaced segment starts from the NdeI restriction enzyme recognition sequence CATATG and ends at the SacI restriction enzyme recognition sequence GAGCTC) to obtain the recombinant plasmid p-DV. The recombinant plasmid has been sequenced and verified. DNA molecule A is an artificially synthesized double-stranded DNA molecule, as shown in positions 552-6764 of SEQ ID No.1. DNA molecule A contains the vioABCE gene cluster. In SEQ ID No.1, nucleotides 555-1811 are vioA gene (coding chain) (vioA gene encodes vioA protein), nucleotides 1812-1828 are RBS sequences, nucleotides 1829-4825 are vioB gene (coding chain) (vioB gene encodes vioB protein), nucleotides 4826-4842 are RBS sequences, nucleotides 4843-6165 are vioC gene (coding chain) (vioC gene encodes vioC protein), nucleotides 6166-6182 are RBS sequences, and nucleotides 6183-6758 are vioE gene (coding chain) (vioE gene encodes vioE protein). Under the sequential action of vioA protein, vioB protein, vioE protein and vioC protein, L-tryptophan is converted into deoxyviolacein (DV).
[0102] DNA molecule B is used to replace the small segment between the BglII enzyme recognition sequence and the XbaI enzyme recognition sequence in the recombinant plasmid p-DV (the replaced segment starts from the BglII enzyme recognition sequence AGATCT and ends at the XbaI enzyme recognition sequence TCTAGA), to obtain the recombinant plasmid pHg-DV. The recombinant plasmid has been sequenced and verified. DNA molecule B is an artificially synthesized double-stranded DNA molecule, as shown in the 1st to 518th positions of SEQ ID No.1. DNA molecule B has a mercury sensing element. In SEQ ID No.1, the nucleotides at positions 7-441 are the merR gene (template chain), and the nucleotides at positions 442-512 are Pmer.
[0103] DNA molecule C is used to replace the small segment between the SacI restriction enzyme recognition sequence and the HindIII restriction enzyme recognition sequence in the recombinant plasmid pHg-DV (the replaced segment starts from the SacI restriction enzyme recognition sequence GAGCTC and ends at the HindIII restriction enzyme recognition sequence AAGCTT) to obtain the recombinant plasmid pHg-DV-A. The recombinant plasmid has been sequenced and verified. DNA molecule C is an artificially synthesized double-stranded DNA molecule, as shown in the 6759-8568th position of SEQ ID No.1. DNA molecule C contains a divalent mercury reductase element. In SEQ ID No.1, the 6765-6867th position is a constitutive promoter, and the 6868-8562th position is the MerA gene (coding chain).
[0104] DNA molecule D is used to replace a small segment between the HindIII restriction enzyme recognition sequence and the XhoI restriction enzyme recognition sequence in the recombinant plasmid pHg-DV-A (the replaced segment starts from the HindIII restriction enzyme recognition sequence AAGCTT and ends with the XhoI restriction enzyme recognition sequence CTCGAG) to obtain the recombinant plasmid pHg-DV-AB. The recombinant plasmid has been sequenced and verified. DNA molecule D is an artificially synthesized double-stranded DNA molecule, as shown in positions 8563-9316 of SEQ ID No.1. DNA molecule D contains an organic mercury lyase element. In SEQ ID No.1, positions 8569-8671 are constitutive promoters, and positions 8672-9310 are merB genes.
[0105] Structural description of the recombinant plasmid pHg-DV-A: The recombinant plasmid was obtained by replacing the small fragment between the restriction sites BglII and HindIII of the pET-21a(+) plasmid with positions 1-8586 of SEQ ID No.1 (the replaced segment starts from the BglII restriction recognition sequence AGATCT and ends at the HindIII restriction recognition sequence AAGCTT).
[0106] Structural description of the recombinant plasmid pHg-DV-AB: The recombinant plasmid was obtained by replacing the small fragment between the restriction sites BglII and XhoI of the pET-21a(+) plasmid with SEQ ID No.1 (the replaced segment starts from the BglII restriction recognition sequence AGATCT and ends with the XhoI restriction recognition sequence CTCGAG).
[0107] Pmer: It is a bidirectional promoter element. One direction is the promoter of the merR gene (MerR protein has basically no inhibitory effect on this promoter), and the other direction is the promoter of the vioABCE gene cluster (MerR protein has binding activity to this promoter and exerts an inhibitory effect).
[0108] At the same time, the recombinant plasmid pHg-DV-B was constructed as a control. The structural description of the recombinant plasmid pHg-DV-B is as follows: the small fragment between the restriction sites BglII and SacI of the pET-21a(+) plasmid was replaced with the 1st to 6764th positions of SEQ ID No.1 (the replaced segment starts from the BglII restriction recognition sequence AGATCT and ends with the SacI restriction recognition sequence GAGCTC), and the small fragment between the HindIII restriction recognition sequence and the XhoI restriction recognition sequence (the replaced segment starts from the HindIII restriction recognition sequence AAGCTT and ends with the XhoI restriction recognition sequence CTCGAG) was replaced with the recombinant plasmid obtained after the 8563rd to 9316th positions of SEQ ID No.1 were replaced.
[0109] 2. Construction of recombinant bacteria
[0110] The recombinant plasmid pHg-DV-A was introduced into Escherichia coli TOP10 competent cells and incubated upside down at 37°C for 12 hours on LB agar plates containing 50 μg / mL ampicillin to obtain recombinant bacteria, which were named recombinant bacteria TOP10 / pHg-DV-A.
[0111] The recombinant plasmid pHg-DV-AB was introduced into Escherichia coli TOP10 competent cells and incubated upside down at 37°C for 12 hours on LB agar plates containing 50 μg / mL ampicillin to obtain recombinant bacteria, which were named recombinant bacteria TOP10 / pHg-DV-AB.
[0112] The recombinant plasmid pHg-DV used as a control was introduced into Escherichia coli TOP10 competent cells and incubated upside down at 37°C for 12 hours on LB agar plates containing 50 μg / mL ampicillin to obtain recombinant bacteria, which were named recombinant bacteria TOP10 / pHg-DV.
[0113] The recombinant plasmid pHg-DV-B used as a control was introduced into Escherichia coli TOP10 competent cells and incubated upside down at 37°C for 12 hours on LB agar plates containing 50 μg / mL ampicillin to obtain recombinant bacteria, which were named recombinant bacteria TOP10 / pHg-DV-B.
[0114] The above-mentioned recombinant bacteria are whole-cell biosensors.
[0115] The recombinant bacteria TOP10 / pHg-DV-A and the control bacteria TOP10 / pHg-DV were used to detect inorganic divalent mercury.
[0116] The recombinant bacteria TOP10 / pHg-DV-AB and the control bacteria TOP10 / pHg-DV-B were used to detect organic mercury.
[0117] 3. Working principle of whole-cell biosensor for detecting inorganic divalent mercury and / or organic mercury
[0118] The schematic diagram of the working principle of using the recombinant bacteria TOP10 / pHg-DV-A to detect inorganic divalent mercury is shown in Figure 1 The principle is as follows: the constitutive promoter starts the expression of the merA gene and encodes the merA protein (mercuric reductase); Pmer acts as a constitutive promoter in one direction to start the merR gene to encode the MerR protein (mercuric ion response transcriptional regulator), the MerR protein binds to and inhibits the promoter activity of Pmer in the other direction, and the vioABCE gene cluster is not expressed; when inorganic mercury (Hg(II)) exists in the environment, the mercuric reductase reduces part of Hg(II) to Hg(0); the unreduced Hg(II) binds to the MerR protein and can change the binding conformation of the MerR protein and Pmer, thereby relieving the inhibition of the MerR protein on Pmer, and the downstream vioABCE gene cluster is expressed. Within a certain range, there is a dose effect between the Hg(II) content and the expression level of the vioABCE gene cluster. The merA protein can improve the tolerance of the whole-cell sensor to high-concentration mercury by reducing part of Hg(II) to Hg(0), which can effectively alleviate the toxic effects of high-concentration mercury on cells. On the other hand, it can shift the detection range of Hg(II) to the right, but still has a dose-effect relationship (i.e., within a higher concentration range, there is a dose-effect between the Hg(II) content and the expression level of the vioABCE gene cluster).
[0119] The schematic diagram of the working principle of detecting organic mercury using the recombinant bacteria TOP10 / pHg-DV-AB is shown in Figure 2The principle is as follows: the constitutive promoter starts the expression of the merA gene and encodes the merA protein (mercuric reductase); the constitutive promoter starts the expression of the merB gene and encodes the merB protein (organomercuric lyase); Pmer acts as a constitutive promoter in one direction to start the merR gene to encode the MerR protein (mercuric ion response transcriptional regulator), the MerR protein binds and inhibits the promoter activity of Pmer in the other direction, and the vioABCE gene cluster is not expressed; when organic mercury exists in the environment, under the action of organic mercury lyase, the C-Hg bond of organic mercury is cleaved, releasing free mercuric ions Hg(II), and the mercuric reductase reduces part of Hg(II) to Hg(0); the unreduced Hg(II) can change the binding conformation of the MerR protein and Pmer after binding to the MerR protein, thereby relieving the inhibition of the MerR protein on Pmer, and the downstream vioABCE gene cluster is expressed. Within a certain range, there is a dose effect between the organic mercury content and the expression level of the vioABCE gene cluster. The merA protein can improve the tolerance of the whole-cell sensor to high-concentration mercury by reducing part of Hg(II) to Hg(0), which can effectively alleviate the toxic effects of high-concentration mercury on cells. On the other hand, it can shift the detection range of organic mercury to the right, but still has a dose-effect relationship (i.e., within a higher concentration range, there is a dose effect between the organic mercury content and the expression level of the vioABCE gene cluster).
[0120] Example 2: Whole-cell biosensor for detecting inorganic divalent mercury and / or organic mercury
[0121] 1. Study on the higher tolerance of recombinant bacteria TOP10 / pHg-DV-A to inorganic mercury (Hg(II)) compared with TOP10
[0122] 1. The recombinant bacteria TOP10 / pHg-DV-A and competent TOP10 constructed in Example 1 were inoculated into 2 mL of liquid LB medium containing 50 μg / mL ampicillin, and cultured overnight at 37°C, 250 rpm, with shaking for 8-12 hours to activate the bacteria.
[0123] 2. Inoculate 1% (volume ratio) of overnight cultured TOP10 / pHg-DV-A and TOP10 bacterial suspension into fresh LB liquid medium containing 50 μg / mL ampicillin, shake culture at 37°C, 250 rpm for 4 hours. After the logarithmic phase, add mercuric chloride to a final concentration of 50 μg / L, and shake culture at 37°C, 250 rpm.
[0124] 3. Take 100 μL of TOP10 / pHg-DV-A and TOP10 culture solution at 0, 4, and 8 hours after adding mercuric chloride, and measure the total mercury concentration in the culture solution using a direct mercury meter (Hydra IIC, Leeman, USA). The results are shown in Table 1 and Figure 3 shown.
[0125] Table 1. Total mercury concentrations in recombinant bacteria TOP10 / pHg-DV-A and TOP10 bacterial suspensions
[0126]
[0127]
[0128] The above results show that after the addition of divalent mercury, the concentration of mercury in the recombinant bacteria TOP10 / pHg-DV-A culture liquid was significantly reduced compared with the empty host bacteria TOP10 culture liquid. This may be because the presence of the merA gene prompts divalent mercury to be converted into volatile zero-valent mercury and released, resulting in the TOP10 / pHg-DV-A bacteria having a higher tolerance to mercury.
[0129] 2. Time-dose response of TOP10 / pHg-DV and TOP10 / pHg-DV-A to mercury (II) ions during the delayed period
[0130] 1. Single colonies of the recombinant bacteria TOP10 / pHg-DV and TOP10 / pHg-DV-A constructed in Example 1 were inoculated into 2 mL of liquid LB medium containing 50 μg / mL ampicillin and cultured overnight in a shaking incubator at 37°C and 250 rpm.
[0131] 2. The recombinant bacteria TOP10 / pHg-DV and TOP10 / pHg-DV-A cultured overnight were added to the liquid LB medium containing 50 μg / mL ampicillin at a ratio of 1% (volume ratio), and mercuric chloride was added to the TOP10 / pHg-DV culture system to a final concentration of 0, 0.02 and 0.05 μM, respectively; mercuric chloride was added to the TOP10 / pHg-DV-A culture system to a final concentration of 0, 1.5 and 4 μM, respectively. Subsequently, the culture was carried out in a shaking incubator at 37°C and 250 rpm for 7 hours, and samples were taken every hour.
[0132] 3. Take 100 μL of the collected samples and place them in a 96-well plate. Use a microplate reader to measure the bacterial concentration at 600 nm.
[0133] 4. Pipette 900 μL of the remaining bacterial solution into a 1.5 mL centrifuge tube, add 360 μL of n-butanol, and vortex for 20 seconds to fully extract the pigment. After vortexing, centrifuge the tube at 12000 rpm for 1 minute. Pipette 100 μL of the supernatant (extracted organic phase) into a 96-well plate and measure the absorbance at 570 nm. The results are shown in Table 2 and Figure 4 As shown in A.
[0134] Table 2. DV pigment absorbance detection values (OD570nm) at different time points during the delay period
[0135]
[0136] The above results show that the delayed phase recombinant bacteria TOP10 / pHg-DV and TOP10 / pHg-DV-A have a dose-response and time-response relationship in response to mercury (II). As the culture time increases, the pigment signal continues to increase; after 4 hours, the increase in pigment signal is not obvious. Therefore, 4 hours was selected as the detection time.
[0137] 3. Sensitivity response of TOP10 / pHg-DV and TOP10 / pHg-DV-A to mercury (II) ions during the delayed period
[0138] 1. Single colonies of the recombinant bacteria TOP10 / pHg-DV and TOP10 / pHg-DV-A constructed in Example 1 were inoculated into 2 mL of liquid LB medium containing 50 μg / mL ampicillin and cultured overnight in a shaking incubator at 37°C and 250 rpm.
[0139] 2. The recombinant bacteria TOP10 / pHg-DV and TOP10 / pHg-DV-A cultured overnight were added to the liquid LB medium containing 50 μg / mL ampicillin at a ratio of 1% (volume ratio), and the stock solution of mercuric chloride was added to the medium by a two-fold dilution method, so that the final concentrations of Hg(II) in the TOP10 / pHg-DV bacterial solution were 3.9063, 1.9531, 0.9766, 0.4883, 0.2441, The final concentrations of Hg(II) in the TOP10 / pHg-DV-A bacterial solution were 125, 62.5, 31.25, 15.625, 7.8125, 3.9063, 1.9531, 0.9766, 0.4883, 0.2441, 0.1221 and 0 μM, respectively. The cells were then cultured in a shaking incubator at 37°C and 250 rpm for 4 hours.
[0140] 3. Take 100 μL of the collected samples and place them in a 96-well plate. Use a microplate reader to measure the bacterial concentration at 600 nm.
[0141] 4. Pipette 900 μL of the remaining bacterial solution into a 1.5 mL centrifuge tube, add 360 μL of n-butanol, and vortex for 20 seconds to fully extract the pigment. After vortexing, centrifuge the tube at 12000 rpm for 1 minute. Pipette 100 μL of the supernatant (extracted organic phase) into a 96-well plate and measure the absorbance at 570 nm. The results are shown in Table 3 and Figure 4 As shown in B.
[0142] Table 3. Absorbance of pigments produced by recombinant bacteria in response to different concentrations of mercury ions during the delayed phase (OD570nm)
[0143]
[0144] Note: The blank spaces in the table indicate that no data was detected.
[0145] The above results showed that the delayed-phase recombinant bacteria TOP10 / pHg-DV and TOP10 / pHg-DV-A had an obvious dose-effect relationship in response to Hg(Ⅱ). Moreover, compared with TOP10 / pHg-DV, TOP10 / pHg-DV-A showed a higher tolerance dose to inorganic mercury.
[0146] 4. Time-dose response of TOP10 / pHg-DV and TOP10 / pHg-DV-A to mercury (II) ions in the logarithmic phase
[0147] 1. Single colonies of the recombinant bacteria TOP10 / pHg-DV and TOP10 / pHg-DV-A constructed in Example 1 were inoculated into 2 mL of liquid LB medium containing 50 μg / mL ampicillin and cultured overnight in a shaking incubator at 37°C and 250 rpm.
[0148] 2. The recombinant bacteria TOP10 / pHg-DV and TOP10 / pHg-DV-A cultured overnight were added to the liquid LB medium containing 50 μg / mL ampicillin at a ratio of 1% (volume ratio), and after culturing for 4 hours to the logarithmic phase, mercuric chloride was added to the TOP10 / pHg-DV culture system to a final concentration of Hg(II) of 0, 0.006 and 0.03 μM; mercuric chloride was added to the TOP10 / pHg-DV-A culture system to a final concentration of Hg(II) of 0, 1 and 15 μM. Subsequently, the culture was carried out in a shaking incubator at 37°C and 250 rpm for 6 hours, and samples were taken every hour.
[0149] 3. Take 100 μL of the collected samples and place them in a 96-well plate. Use a microplate reader to measure the bacterial concentration at 600 nm.
[0150] 4. Pipette 900 μL of the remaining bacterial solution into a 1.5 mL centrifuge tube, add 360 μL of n-butanol, and vortex for 20 seconds to fully extract the pigment. After vortexing, centrifuge the tube at 12000 rpm for 1 minute. Pipette 100 μL of the supernatant (extracted organic phase) into a 96-well plate and measure the absorbance at 570 nm. The results are shown in Table 4 and Figure 5 As shown in A.
[0151] Table 4. DV pigment absorbance detection values (OD570nm) at different time points in the logarithmic phase
[0152]
[0153] The above results show that the logarithmic phase recombinant bacteria TOP10 / pHg-DV and TOP10 / pHg-DV-A have a dose-response and time-response relationship in response to mercury (II). As the culture time increases, the pigment signal continues to increase; after 4 hours, the increase in pigment signal is not obvious. Therefore, 4 hours was selected as the detection time.
[0154] 5. Sensitivity response of TOP10 / pHg-DV and TOP10 / pHg-DV-A to mercury (II) ions in the logarithmic phase
[0155] 1. A single colony of the recombinant bacteria TOP10 / pHg-DV and TOP10 / pHg-DV-A constructed in Example 1 was inoculated into 2 mL of liquid LB medium containing 50 μg / mL ampicillin and cultured overnight in a shaking incubator at 37°C and 250 rpm.
[0156] 2. The recombinant bacteria TOP10 / pHg-DV and TOP10 / pHg-DV-A cultured overnight were added to liquid LB medium containing 50 μg / mL ampicillin at a ratio of 1% (volume ratio). After culturing for 4 hours to the logarithmic phase, the stock solution of mercuric chloride was added to the medium by a two-fold dilution method, so that the final concentrations of Hg(II) in the TOP10 / pHg-DV bacterial solution were 0.0610 μM, 0.0305, 0.0153, 0.0076, and 0.0 The final concentrations of Hg(II) in the TOP10 / pHg-DV-A bacterial solution were 500, 250, 125, 62.5, 31.25, 15.625, 7.8125, 3.9063, 1.9531, 0.9766, 0.4883, 0.2441, 0.1221, 0.0610, 0.0305 and 0 μM, respectively. The cells were then cultured in a shaking incubator at 37°C and 250 rpm for 4 hours.
[0157] 3. Take 100 μL of the collected samples and place them in a 96-well plate. Use a microplate reader to measure the bacterial concentration at 600 nm.
[0158] 4. Pipette 900 μL of the remaining bacterial solution into a 1.5 mL centrifuge tube, add 360 μL of n-butanol, and vortex for 20 seconds to fully extract the pigment. After vortexing, centrifuge the tube at 12000 rpm for 1 minute. Pipette 100 μL of the supernatant (extracted organic phase) into a 96-well plate and measure the absorbance at 570 nm. The results are shown in Table 5 and Figure 5 As shown in B.
[0159] Table 5. Absorbance of pigments produced by recombinant bacteria in the logarithmic phase in response to different concentrations of mercury ions (OD570nm)
[0160]
[0161] Note: The blank spaces in the table indicate that no data was detected.
[0162] The above results showed that the logarithmic phase recombinant bacteria TOP10 / pHg-DV and TOP10 / pHg-DV-A had a significant dose-effect relationship in response to Hg(Ⅱ). Moreover, compared with TOP10 / pHg-DV, TOP10 / pHg-DV-A showed a higher tolerance dose to inorganic mercury.
[0163] 6. Selective Interference Determination
[0164] 1. A single colony of TOP10 / pHg-DV-A constructed in Example 1 was inoculated into 2 mL of liquid LB medium containing 50 μg / mL ampicillin and cultured overnight in a shaking incubator at 37° C. and 250 rpm.
[0165] 2. Dilute the activated bacterial biosensor (i.e., recombinant bacteria TOP10 / pHg-DV-A) in fresh LB broth at a volume ratio of 1:100. Perform the following two experiments:
[0166] Different single metal matrices were added to the bacterial culture, including Hg(II) with a final concentration of 4 μM, and single metal ions of Pb(II), Fe(II), Mg(II), Mn(II), Cu(II), Zn(II), and Cd(II) with a final concentration of 4 μM.
[0167] Different mixed metal matrices were added to the bacterial culture, and a mixture of any or all of the metal ions Pb(II), Fe(II), Mg(II), Mn(II), Cu(II), Zn(II), and Cd(II) with a final concentration of 4 μM and 4 μM Hg(II). "All+Hg(II)" means a mixture of all of the metal ions Pb(II), Fe(II), Mg(II), Mn(II), Cu(II), Zn(II), and Cd(II) with a final concentration of 4 μM and 4 μM Hg(II). "All without Hg(II)" means a mixture of all of the metal ions Pb(II), Fe(II), Mg(II), Mn(II), Cu(II), Zn(II), and Cd(II) with a final concentration of 4 μM without Hg(II).
[0168] A negative control group was also set up without adding any metals.
[0169] 3. Incubate in a shaking incubator at 37°C and 250 rpm for 4 hours.
[0170] 4. Take 100 μL of the collected samples and place them in a 96-well plate. Use a microplate reader to measure the bacterial concentration at 600 nm.
[0171] 5. Pipette 900 μL of the remaining bacterial solution into a 1.5 mL centrifuge tube, add 360 μL of n-butanol, and vortex for 20 seconds to fully extract the pigment. After vortexing, centrifuge the tube at 12000 rpm for 1 minute. Pipette 100 μL of the supernatant (extracted organic phase) into a 96-well plate and measure the absorbance at 570 nm. The results are shown in Table 6 and Figure 6 shown. Figure 6 In the figure, A is the response diagram of TOP10 / pHg-DV-A to mercury under different single metal interference conditions and representative photos of recombinant bacterial extracts; B is the response diagram of TOP10 / pHg-DV-A to mercury under different mixed metal interference conditions and representative photos of recombinant bacterial extracts.
[0172] Table 6. Absorbance and bacterial concentration of pigments produced by recombinant bacteria TOP10 / pHg-DV-A in response to different metal ions
[0173]
[0174]
[0175] The above results show that the recombinant bacteria TOP10 / pHg-DV-A has high selectivity for Hg(II) and anti-interference in the presence of other metal ions.
[0176] 7. Study on the higher tolerance of recombinant bacteria TOP10 / pHg-DV-AB to organic mercury than TOP10
[0177] 1. The recombinant bacteria TOP10 / pHg-DV-AB and competent TOP10 constructed in Example 1 were inoculated into 2 mL of liquid LB medium containing 50 μg / mL ampicillin, and cultured overnight at 37°C, 250 rpm, with shaking for 8-12 hours to activate the bacteria.
[0178] 2. Inoculate 1% (volume ratio) of overnight cultured TOP10 / pHg-DV-AB and TOP10 bacterial suspension into fresh LB liquid medium (containing 50 μg / mL ampicillin), culture at 37°C, 250 rpm with shaking for 4 hours until the logarithmic phase, then add methylmercuric chloride to a final concentration of 150 μg / L, and culture at 37°C, 250 rpm with shaking.
[0179] 3. Take 100 μL of the culture solution TOP10 / pHg-DV-AB and TOP10 at 0, 4 and 8 hours after adding methylmercuric chloride, and use a direct mercury meter to measure the total mercury concentration in the culture solution. The results are shown in Table 7 and Figure 7 shown.
[0180] Table 7. Total mercury concentrations in recombinant bacteria TOP10 / pHg-DV-AB and TOP10 bacterial suspensions
[0181]
[0182] The above results show that after the addition of methylmercury, the concentration of mercury in the recombinant bacteria TOP10 / pHg-DV-AB was significantly reduced compared with the bacterial liquid of the empty host bacteria TOP10. This may be because the presence of the merB gene prompted the decomposition of methylmercury into divalent mercury, and then the merA gene converted the divalent mercury into volatile zero-valent mercury and released it, resulting in the TOP10 / pHg-DV-AB bacteria having a higher tolerance to methylmercury.
[0183] 8. Time-dose response of TOP10 / pHg-DV-B and TOP10 / pHg-DV-AB to methylmercury chloride in the delayed period
[0184] 1. Single colonies of TOP10 / pHg-DV-B and TOP10 / pHg-DV-AB constructed in Example 1 were inoculated into 2 mL of liquid LB medium containing 50 μg / mL ampicillin and cultured overnight in a shaking incubator at 37°C and 250 rpm.
[0185] 2. The recombinant bacteria TOP10 / pHg-DV-B and TOP10 / pHg-DV-AB cultured overnight were added to the liquid LB medium containing 50 μg / mL ampicillin at a ratio of 1% (volume ratio), CH3ClHg was added to the TOP10 / pHg-DV-B culture system to a final concentration of 0, 0.008 and 0.02 μM, respectively; CH3ClHg was added to the TOP10 / pHg-DV-AB culture system to a final concentration of 0, 0.4 and 1.5 μM, respectively. Subsequently, the culture was carried out in a shaking incubator at 37°C and 250 rpm for 9 hours, and samples were taken every hour.
[0186] 3. Take 100 μL of the collected samples and place them in a 96-well plate. Use a microplate reader to measure the bacterial concentration at 600 nm.
[0187] 4. Pipette 900 μL of the remaining bacterial solution into a 1.5 mL centrifuge tube, add 360 μL of n-butanol, and vortex for 20 seconds to fully extract the pigment. After vortexing, centrifuge the tube at 12000 rpm for 1 minute. Pipette 100 μL of the supernatant (extracted organic phase) into a 96-well plate and measure the absorbance at 570 nm. The results are shown in Table 8 and Figure 8 As shown in A.
[0188] Table 8. DV pigment absorbance detection values (OD570nm) at different time points during the delay period
[0189]
[0190] The above results show that the delayed phase recombinant bacteria TOP10 / pHg-DV-B and TOP10 / pHg-DV-AB respond to CH3ClHg in a dose-response and time-response relationship. As the culture time increases, the pigment signal continues to increase; after 5 hours, the increase in pigment signal is not obvious. Therefore, 5 hours was selected as the detection time.
[0191] IX. Sensitivity response of TOP10 / pHg-DV-B and TOP10 / pHg-DV-AB to methylmercury chloride during the delayed period
[0192] 1. Single colonies of TOP10 / pHg-DV-B and TOP10 / pHg-DV-AB constructed in Example 1 were inoculated into 2 mL of liquid LB medium containing 50 μg / mL ampicillin, and cultured overnight in a shaking incubator at 37° C. and 250 rpm.
[0193] 2. The recombinant bacteria TOP10 / pHg-DV-B and TOP10 / pHg-DV-AB cultured overnight were added to the liquid LB medium containing 50 μg / mL ampicillin at a ratio of 1% (volume ratio), and the stock solution of CH3ClHg was added to the medium by a two-fold dilution method, so that the final concentrations of CH3ClHg in the TOP10 / pHg-DV-B bacterial solution were 0.4883, 0.2441, and 0.12, respectively. 21, 0.0610, 0.0305, 0.0153, 0.0076, 0.0038, 0.0019, 0.00095, 0.000475 and 0 μM; the final concentrations of CH3ClHg in the TOP10 / pHg-DV-AB bacterial solution were 15.625, 7.8125, 3.9063, 1.9531, 0.9766, 0.4883, 0.2441, 0.1221 and 0 μM, respectively. The cells were then cultured in a shaking incubator at 37°C and 250 rpm for 5 hours.
[0194] 3. Take 100 μL of the collected samples and place them in a 96-well plate. Use a microplate reader to measure the bacterial concentration at 600 nm.
[0195] 4. Pipette 900 μL of the remaining bacterial solution into a 1.5 mL centrifuge tube, add 360 μL of n-butanol, and vortex for 20 seconds to fully extract the pigment. After vortexing, centrifuge the tube at 12000 rpm for 1 minute. Pipette 100 μL of the supernatant (extracted organic phase) into a 96-well plate and measure the absorbance at 570 nm. The results are shown in Table 9 and Figure 8 As shown in B.
[0196] Table 9. Absorbance (OD570nm) of pigments produced by recombinant bacteria in response to different concentrations of MeHg during the delayed phase
[0197]
[0198] Note: The blank spaces in the table indicate that no data was detected.
[0199] The above results show that there is an obvious dose-effect relationship between the delayed-phase recombinant bacteria TOP10 / pHg-DV-B and TOP10 / pHg-DV-AB in response to CH3ClHg. Moreover, compared with TOP10 / pHg-DV-B, TOP10 / pHg-DV-AB showed a higher tolerance dose to CH3ClHg.
[0200] 10. Time-dose response of TOP10 / pHg-DV-B and TOP10 / pHg-DV-AB to methylmercury chloride in the logarithmic phase
[0201] 1. Single colonies of the recombinant bacteria TOP10 / pHg-DV-B and TOP10 / pHg-DV-AB constructed in Example 1 were inoculated into 2 mL of liquid LB medium containing 50 μg / mL ampicillin and cultured overnight in a shaking incubator at 37°C and 250 rpm.
[0202] 2. The recombinant bacteria TOP10 / pHg-DV-B and TOP10 / pHg-DV-AB cultured overnight were added to the liquid LB medium containing 50 μg / mL ampicillin at a ratio of 1% (volume ratio), and after culturing for 4 hours to the logarithmic phase, CH3ClHg was added to the TOP10 / pHg-DV-B culture system to a final concentration of 0, 0.03 and 0.2 μM, respectively; CH3ClHg was added to the TOP10 / pHg-DV-AB culture system to a final concentration of 0, 1.8 and 7 μM, respectively. Subsequently, the culture was carried out in a shaking incubator at 37°C and 250 rpm for 7 hours, and samples were taken every hour.
[0203] 3. Take 100 μL of the collected samples and place them in a 96-well plate. Use a microplate reader to measure the bacterial concentration at 600 nm.
[0204] 4. Pipette 900 μL of the remaining bacterial solution into a 1.5 mL centrifuge tube, add 360 μL of n-butanol, and vortex for 20 seconds to fully extract the pigment. After vortexing, centrifuge the tube at 12000 rpm for 1 minute. Pipette 100 μL of the supernatant (extracted organic phase) into a 96-well plate and measure the absorbance at 570 nm. The results are shown in Table 10 and Fig. 9 As shown in A.
[0205] Table 10. DV pigment absorbance detection values at different time points in the logarithmic phase
[0206]
[0207] The above results show that the logarithmic phase recombinant bacteria TOP10 / pHg-DV-AB responds to MeHg in a dose-response and time-response relationship. As the culture time increases, the pigment signal continues to increase; after 3 hours, the pigment signal tends to stabilize. Therefore, 3 hours was selected as the detection time.
[0208] XI. Sensitivity response of TOP10 / pHg-DV-B and TOP10 / pHg-DV-AB to methylmercury chloride in logarithmic period
[0209] 1. Single colonies of the recombinant bacteria TOP10 / pHg-DV-B and TOP10 / pHg-DV-AB constructed in Example 1 were inoculated into 2 mL of liquid LB medium containing 50 μg / mL ampicillin and cultured overnight in a shaking incubator at 37°C and 250 rpm.
[0210] 2. The recombinant bacteria TOP10 / pHg-DV-B and TOP10 / pHg-DV-AB cultured overnight were added to the liquid LB medium containing 50 μg / mL ampicillin at a ratio of 1% (volume ratio). After culturing for 4 hours to the logarithmic phase, the stock solution of CH3ClHg was added to the medium by a two-fold dilution method, so that the final concentrations of CH3ClHg in the TOP10 / pHg-DV-B bacterial solution were 15.625, 7.8125, 3.9063, 1.9531, 0.9766, and 0.4 883, 0.2441, 0.1221, 0.0610, 0.0305, 0.0153, 0.0076, 0.0038, 0.0019, 0.00095, 0.000475 and 0 μM; the final concentrations of CH3ClHg in the TOP10 / pHg-DV-BA bacterial solution were 125, 62.5, 31.25, 15.625, 7.8125, 3.9063, 1.9531, 0.9766, 0.4883, 0.2441, 0.1221 and 0 μM, respectively. The cells were then cultured in a shaking incubator at 37°C and 250 rpm for 3 hours.
[0211] 3. Take 100 μL of the collected samples and place them in a 96-well plate. Use a microplate reader to measure the bacterial concentration at 600 nm.
[0212] 4. Pipette 900 μL of the remaining bacterial solution into a 1.5 mL centrifuge tube, add 360 μL of n-butanol, and vortex for 20 seconds to fully extract the pigment. After vortexing, centrifuge the tube at 12000 rpm for 1 minute. Pipette 100 μL of the supernatant (extracted organic phase) into a 96-well plate and measure the absorbance at 570 nm. The results are shown in Table 11 and Fig. 9 As shown in B.
[0213] Table 11. Absorbance (OD570nm) of pigments produced by recombinant bacteria in logarithmic phase in response to different concentrations of CH3ClHg
[0214]
[0215] Note: The blank spaces in the table indicate that no data was detected.
[0216] The above results show that the logarithmic phase recombinant bacteria TOP10 / pHg-DV-B and TOP10 / pHg-DV-AB have an obvious dose-effect relationship in response to CH3ClHg. Moreover, compared with TOP10 / pHg-DV-B, TOP10 / pHg-DV-AB showed a higher tolerance dose to CH3ClHg.
[0217] 12. TOP10 / pHg-DV-AB can respond to a variety of organic mercury
[0218] 1. A single colony of the recombinant bacteria TOP10 / pHg-DV-AB constructed in Example 1 was inoculated into 2 mL of liquid LB medium containing 50 μg / mL ampicillin and cultured overnight in a shaking incubator at 37° C. and 250 rpm.
[0219] 2. The recombinant bacteria TOP10 / pHg-DV-AB cultured overnight was added to a liquid LB medium containing 50 μg / mL ampicillin at a ratio of 1% (volume ratio), and different stock solutions of organic mercury (see Table 12) were added to the culture system by a two-fold dilution method to form different final concentrations. Then, the culture was carried out in a shaking incubator at 37°C and 250 rpm for 5 hours.
[0220] 3. Take 100 μL of the collected samples and place them in a 96-well plate. Use a microplate reader to measure the bacterial concentration at 600 nm.
[0221] 4. Pipette 900 μL of the remaining bacterial solution into a 1.5 mL centrifuge tube, add 360 μL of n-butanol, and vortex for 20 seconds to fully extract the pigment. After vortexing, centrifuge the tube at 12000 rpm for 1 minute. Pipette 100 μL of the supernatant (extracted organic phase) into a 96-well plate and measure the absorbance at 570 nm. The results are shown in Table 12 and Fig.10 shown.
[0222] Table 12. Absorbance of pigments produced by recombinant bacteria to different concentrations of organic mercury (OD570nm)
[0223]
[0224] Note: The blank spaces in the table indicate that no data was detected.
[0225] 13. Biosensor Cell Stability Assay
[0226] In order to evaluate the stability of engineered bacteria during passage, the recombinant bacteria TOP10 / pHg-DV-A and TOP10 / pHg-DV-AB constructed in Example 1 were cultured overnight and activated and then continuously passaged. The responses of TOP10 / pHg-DV-A sensor cells to 0, 1.5 and 4 μM mercuric chloride, and the responses of TOP10 / pHg-DV-AB sensor cells to 0, 0.5 and 1.5 μM CH3ClHg were evaluated at the 1st and 5th passages, respectively.
[0227] 1. Single colonies of TOP10 / pHg-DV-A and TOP10 / pHg-DV-AB constructed in Example 1 were inoculated into 2 mL of liquid LB medium containing 50 μg / mL ampicillin, and cultured overnight in a shaking incubator at 37°C and 250 rpm.
[0228] 2. Dilute the activated bacterial biosensor in fresh LB broth at a volume ratio of 1:100 to obtain the first generation.
[0229] 3. The stock solution of mercuric chloride was added to the recombinant bacteria TOP10 / pHg-DV-A so that its final Hg(II) concentration was 0, 1.5, and 4 μM, respectively, and the culture was carried out in a shaking incubator at 37°C and 250 rpm for 4 hours, and the bacterial solution concentration (OD600) and absorbance (OD570) were detected according to the above method; the stock solution of methylmercuric chloride was added to the recombinant bacteria TOP10 / pHg-DV-AB so that its final CH3ClHg concentration was 0, 0.5, and 1.5 μM, respectively, and the culture was carried out in a shaking incubator at 37°C and 250 rpm for 5 hours, and the bacterial solution concentration (OD600) and absorbance (OD570) were detected according to the above method.
[0230] 4. Take 20 μL of the bacterial solution from step 1 and inoculate it into 2 mL of liquid LB medium and culture it in a shaking incubator at 37°C and 250 rpm for 12 h to obtain the second generation. Repeat step 3 to detect the bacterial solution concentration (OD600) and absorbance (OD570). The results are shown in Table 13 and Fig.11 shown.
[0231] Table 13. The bacterial concentration and absorbance of the pigment produced by the recombinant bacteria during subculture
[0232]
[0233]
[0234] The above results showed that the recombinant bacteria TOP10 / pHg-DV-A and TOP10 / pHg-DV-AB were stable within five generations.
[0235] 14. Sensitivity responses of TOP10 / pHg-DV and TOP10 / pHg-DV-A to urinary inorganic mercury (Hg(II))
[0236] 1. The overnight culture of the recombinant bacteria TOP10 / pHg-DV and TOP10 / pHg-DV-A constructed in Example 1 was added to a culture medium containing 50 μg / mL ampicillin at a ratio of 1% (volume ratio) (wherein, artificial urine (Feijing Biotechnology Co., Ltd., PH1879) sample accounted for 20%; 10×LB liquid culture medium accounted for 10%; sterile water accounted for 70%. Each % represents volume percentage). The stock solution of mercuric chloride was added to the culture system by a two-fold dilution method to make the artificial urine sample in TOP10 / pHg- The urinary mercury contents in the DV system were 0.9766, 0.4883, 0.2441, 0.1221, 0.0610, 0.0305, 0.0153, 0.0076, 0.0038, 0.0019, 0.00095, 0.000475 and 0 μM, respectively; the urinary mercury contents in the TOP10 / pHg-DV-A system were 125, 62.5, 31.25, 15.625, 7.8125, 3.9063, 1.9531, 0.9766, 0.4883, 0.2441, 0.1221 and 0 μM, respectively. The cells were then cultured in a shaking incubator at 37°C and 250 rpm for 4 hours.
[0237] 2. Take 100 μL of the collected samples and place them in a 96-well plate. Use a microplate reader to measure the bacterial concentration at 600 nm.
[0238] 3. Pipette 900 μL of the remaining bacterial solution into a 1.5 mL centrifuge tube, add 360 μL of n-butanol, and vortex for 20 seconds to fully extract the pigment. After vortexing, centrifuge the tube at 12000 rpm for 1 minute. Pipette 100 μL of the supernatant (extracted organic phase) into a 96-well plate and measure the absorbance at 570 nm. The results are shown in Table 14 and Fig.12 shown.
[0239] Table 14. Absorbance of pigments produced by recombinant bacteria to different concentrations of urinary mercury (OD570nm)
[0240]
[0241]
[0242] Note: The blank spaces in the table indicate that no data was detected.
[0243] The above results show that the response of recombinant bacteria TOP10 / pHg-DV and TOP10 / pHg-DV-A to urinary mercury has an obvious dose-effect relationship, and the dose-effect curve can be drawn within a certain range, which has application potential in the quantitative detection of urinary mercury.
[0244] TOP10 / pHg-DV has a good linear fit (R 2 =0.995)( Fig.12 In the middle (B), when Hg(II) = 0.0038 μM, the absorbance value was significantly different from that at 0 concentration (P < 0.05). TOP10 / pHg-DV-A had a good linear fitting result in the range of 0.9766-15.625 μM urinary mercury Hg(II) (R 2 =0.996)( Fig.12 (C), when Hg(II) = 1.9531 μM, the absorbance value was significantly different from that at 0 concentration (P<0.05).
[0245] 15. Sensitivity responses of TOP10 / pHg-DV-B and TOP10 / pHg-DV-AB to blood organic mercury
[0246] 1. Pre-treatment of blood samples
[0247] 1.1 Each blood sample was divided into two parts, named blood sample 1 and blood sample 2. CH3ClHg stock solution was added to blood sample 1 for spike treatment, so that the concentration of blood mercury was 160 μM; blood sample 2 was not spiked.
[0248] 1.2 Add the extract (formula: a mixture of 0.2% thiourea, 0.1% disodium citrate, 0.1% sodium ethylenediaminetetraacetate and 0.15% potassium chloride; each percentage sign indicates the mass percentage) to blood sample 1 and blood sample 2 in a ratio of 1:1 (volume ratio), let it stand for 1 minute, and then add 15% HNO3 to make the ratio of the extracted blood sample to nitric acid be 1:1 (volume ratio). Vortex and shake for 5 minutes to allow the blood sample to fully react with 15% HNO3. Centrifuge at 12000 rpm for 5 minutes, remove the supernatant, centrifuge again at 12000 rpm for 5 minutes, and transfer the supernatant.
[0249] 1.3 The pH of the supernatant was adjusted to 4-7 with 20% NaOH to obtain sample 1 and sample 2 (corresponding to the above blood sample 1 and blood sample 2, respectively).
[0250] 2. Sensitivity response to blood mercury
[0251] 2.1 The recombinant bacteria TOP10 / pHg-DV-B, TOP10 / pHg-DV-AB and TOP10 / pHg-DV constructed in Example 1, which were cultured overnight, were added at a ratio of 1% (volume ratio) to a culture medium containing 50 μg / mL ampicillin (wherein the blood sample (i.e., "sample 1 / sample 2" after treatment in step 1 above) accounted for 20%; the rhamnolipid sample accounted for 0.6%; the 10×LB liquid culture medium accounted for 10%; the sterile water accounted for 69.4%; each percentage sign indicated the volume percentage).
[0252] 2.2 The culture system containing sample 1 was added to the culture system containing sample 2 by double dilution. The final concentrations of CH3ClHg in the culture systems of recombinant bacteria TOP10 / pHg-DV-B and TOP10 / pHg-DV were 0.0156, 0.0078, 0.0039, 0.00195, 0.00098, 0.00049, 0.00024, 0.000122, 0.000061 and 0 μM, and the final concentrations of CH3ClHg in the culture system of recombinant bacteria TOP10 / pHg-DV-AB were 4, 2, 1, 0.5, 0.25, 0.125, 0.0625, 0.03125, 0.0156, 0.0078 and 0 μM. The culture was then cultured in a shaking incubator at 37°C and 250 rpm for 5 hours.
[0253] 2.3 Take 100 μL of the collected samples and place them in a 96-well plate. Use a microplate reader to measure the bacterial concentration at 600 nm.
[0254] 2.4 Pipette 900 μL of the remaining bacterial solution into a 1.5 mL centrifuge tube, add 360 μL of n-butanol, and vortex for 20 seconds to fully extract the pigment. After vortexing, centrifuge the tube at 12000 rpm for 1 minute. Pipette 100 μL of the supernatant (extracted organic phase) into a 96-well plate and measure the absorbance at 570 nm. The results are shown in Table 15 and Fig.13 shown.
[0255] Table 15. Absorbance of pigments produced by recombinant bacteria to different concentrations of blood mercury (OD570nm)
[0256]
[0257]
[0258] Note: The blank spaces in the table indicate that no data was detected.
[0259] The above results show that the recombinant bacteria TOP10 / pHg-DV cannot detect the presence of Hg(II), indicating that the added extract and nitric acid will not decompose methylmercury. The recombinant bacteria TOP10 / pHg-DV-B and TOP10 / pHg-DV-AB have a significant dose-effect relationship in response to blood mercury, and can draw a dose-effect curve within a certain range, which has application potential in the quantitative detection of blood mercury.
[0260] The recombinant bacteria TOP10 / pHg-DV-B had a good fit in the range of 0.00098-0.0078 μM blood mercury CH3ClHg (R 2 =0.999)( Fig.13 In B), when CH3ClHg = 0.000061 μM, the absorbance value was significantly different from that at 0 concentration (P < 0.05); TOP10 / pHg-DV-AB had a good fit in the range of 0.125-1 μM blood mercury CH3ClHg (R 2 =0.999)( Fig.13 (C), when CH3ClHg = 0.0078 μM, the absorbance value was significantly different from that at 0 concentration (P < 0.05).
[0261] The present invention has been described in detail above. For those skilled in the art, without departing from the purpose and scope of the present invention, and without the need to carry out unnecessary experimental conditions, the present invention can be implemented in a wide range under equivalent parameters, concentrations and conditions. Although the present invention provides specific embodiments, it should be understood that the present invention can be further improved. In a word, according to the principles of the present invention, the application is intended to include any changes, uses or improvements to the present invention, including departure from the disclosed scope in the application, and changes made with conventional techniques known in the art.
Claims
1. Recombinant bacteria, which is recombinant bacteria A or recombinant bacteria B; The recombinant bacteria A is obtained by introducing a recombinant vector A into a recipient bacterium; the recombinant vector A contains a DNA fragment A; the DNA fragment A contains a mercury sensing element, a vioABCE gene cluster and a divalent mercury reductase element; The recombinant bacteria B is obtained by introducing a recombinant vector B into a recipient bacterium; the recombinant vector B contains a DNA fragment B; the DNA fragment B contains the mercury sensing element, the vioABCE gene cluster, the organic mercury lyase element and the divalent mercury reductase element; The mercury sensing element includes merR gene and Pmer; The divalent mercury reductase element includes a constitutively expressed merA gene; The organomercury lyase element includes a constitutively expressed merB gene; The merR gene encodes a mercury ion-responsive transcriptional regulator, namely, the merR protein; The merA gene encodes divalent mercury reductase, i.e., merA protein; The merB gene encodes an organic mercury lyase, i.e., the merB protein; The Pmer is a bidirectional promoter, which activates the expression of the merR gene in one direction and activates the expression of the vioABCE gene cluster in the other direction; The vioABCE gene cluster encodes vioA protein, vioB protein, vioC protein and vioE protein.
2. The recombinant bacterium according to claim 1, characterized in that: The nucleotide sequence of the Pmer is positions 442-512 of SEQ ID No. 1; and / or The amino acid sequence of the MerR protein is shown in SEQ ID No. 2; and / or The amino acid sequence of the VioA protein is shown in SEQ ID No. 3; and / or The amino acid sequence of the VioB protein is shown in SEQ ID No. 4; and / or The amino acid sequence of the VioC protein is shown in SEQ ID No.5; and / or The amino acid sequence of the VioE protein is shown in SEQ ID No.6; and / or The amino acid sequence of the MerA protein is shown in SEQ ID No.7; and / or The amino acid sequence of the MerB protein is shown in SEQ ID No.
8.
3. The recombinant bacterium according to claim 1 or 2, characterized in that: The nucleotide sequence of the MerR gene is the reverse complementary sequence of positions 7-441 of SEQ ID No. 1; and / or The nucleotide sequence of the gene encoding the VioA protein is positions 555-1811 of SEQ ID No. 1; and / or The nucleotide sequence of the gene encoding the VioB protein is 1829-4825 of SEQ ID No. 1; and / or The nucleotide sequence of the gene encoding the VioC protein is positions 4843-6165 of SEQ ID No. 1; and / or The nucleotide sequence of the gene encoding the VioE protein is positions 6183-6758 of SEQ ID No. 1; and / or Further, the nucleotide sequence of the vioABCE gene is positions 555-6758 of SEQ ID No. 1; and / or The nucleotide sequence of MerA is positions 6868-8562 of SEQ ID No.1; and / or The nucleotide sequence of MerB is positions 8672-9310 of SEQ ID No.
1.
4. The recombinant bacterium according to any one of claims 1 to 3, characterized in that: The nucleotide sequence of the DNA fragment A is positions 1 to 8568 of SEQ ID No. 1; The nucleotide sequence of the DNA fragment B is SEQ ID No.
1.
5. The recombinant bacterium according to any one of claims 1 to 4, characterized in that: The recombinant vector A is obtained by replacing the small fragment between the restriction sites BglII and HindIII of the pET-21a(+) plasmid with the DNA fragment A; The recombinant vector B is obtained by replacing the small fragment between the restriction sites BglII and XhoI of the pET-21a(+) plasmid with the DNA fragment B.
6. The recombinant bacterium according to any one of claims 1 to 5, characterized in that: The recipient bacteria is Escherichia coli; Furthermore, the Escherichia coli is Escherichia coli TOP10.
7. Any of the following applications: (A1) Use of the recombinant bacterium A described in any one of claims 1 to 6 as or in the preparation of a whole-cell biosensor for detecting inorganic divalent mercury; (A2) Use of the recombinant bacterium B according to any one of claims 1 to 6 as or in the preparation of a whole-cell biosensor for detecting organic mercury.
8. Any of the following products or applications: P1, the recombinant vector A according to any one of claims 1 to 6; P2, the recombinant vector B according to any one of claims 1 to 6; P3, the DNA fragment A according to any one of claims 1 to 6; P4, the DNA fragment B according to any one of claims 1 to 6; Use of the recombinant vector A in P5 and P1 or the DNA fragment A in P3 in preparing the recombinant bacteria A in any one of claims 1 to 6; Use of the recombinant vector B described in P6 and P2 or the DNA fragment B described in P4 in the preparation of the recombinant bacteria B described in any one of claims 1 to 6; Use of the recombinant vector A described in P7 and P1, the DNA fragment A described in P3, or the recombinant bacterium A described in any one of claims 1 to 6 in the preparation of a kit for detecting inorganic divalent mercury; Use of the recombinant vector B described in P8 and P2, or the DNA fragment B described in P4, or the recombinant bacterium B described in any one of claims 1 to 6 in the preparation of a kit for detecting organic mercury; P9. A kit for detecting inorganic divalent mercury, any one of the following (a1) to (a3): (a1) containing the recombinant bacterium A described in any one of claims 1 to 6; (a2) containing the recombinant vector A and the recipient bacteria described in P1; (a3) containing the DNA fragment A, expression vector and recipient bacteria described in P3; P10. A kit for detecting organic mercury, any one of the following (b1) to (b3): (b1) containing the recombinant bacterium B described in any one of claims 1 to 6; (b2) containing the recombinant vector B and the recipient bacteria described in P2; (b3) containing the DNA fragment B described in P4, an expression vector and a recipient bacterium; Application of the kit described in P11 and P9 in detecting inorganic divalent mercury; Application of the kit described in P12 and P10 in the detection of organic mercury.
9. Either of the following methods: Method I: A method for detecting inorganic divalent mercury, comprising the following steps: co-incubating the recombinant bacteria A described in any one of claims 1 to 6 with a test sample; Method II: A method for detecting organic mercury, comprising the following steps: co-incubating the recombinant bacterium B described in any one of claims 1 to 6 with a test sample.
10. The method according to claim 9, characterized in that: In the method I, the content of inorganic divalent mercury in the test sample is 0.9766-15.625 μM; and / or In the method II, the content of organic mercury in the test sample is 0.125-1 μM.
Citation Information
Patent Citations
Whole-cell biosensor for detecting organic mercury, kit and application
CN117737105A
